AMINA SPIJODIC: Open Payments
NPI 1770357287 · BALLWIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,150 in 57 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $525 · 2025 $1,150
Food & beverage: $1,150
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $227 |
| Lilly USA, LLC | 9 | $163 |
| Novo Nordisk Inc | 6 | $97 |
| Boston Scientific Corporation | 1 | $87 |
| ABBVIE INC. | 3 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $57 |
| Exact Sciences Corporation | 3 | $55 |
| Amgen Inc. | 3 | $52 |
| PFIZER INC. | 3 | $52 |
Products named: MOUNJARO, FARXIGA, WATCHMAN Access System, JARDIANCE, LINZESS, Kerendia, BREZTRI, Cologuard Collection Kit.
Industry payments across MO — which companies pay providers there.
